Spectral Med Price To Sales vs. Debt To Equity
| EDT Stock | CAD 0.56 0.03 5.66% |
Spectral Med Price To Sales Ratio |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.78 | 0.4143 |
|
|
For Spectral Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Spectral Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Spectral Med utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Spectral Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Spectral Med over time as well as its relative position and ranking within its peers.
Spectral |
Spectral Med Debt To Equity vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Spectral Med's current stock value. Our valuation model uses many indicators to compare Spectral Med value to that of its competitors to determine the firm's financial worth. Spectral Med is one of the top stocks in price to sales category among its peers. It also is one of the top stocks in debt to equity category among its peers fabricating about 0.20 of Debt To Equity per Price To Sales. The ratio of Price To Sales to Debt To Equity for Spectral Med is roughly 5.11 . At this time, Spectral Med's Price To Sales Ratio is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Spectral Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Spectral Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Spectral Debt To Equity vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Spectral Med |
| = | 83.31 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Spectral Med |
| = | 16.30 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Spectral Debt To Equity Comparison
Spectral Med is currently under evaluation in debt to equity category among its peers.
Spectral Med Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Spectral Med, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Spectral Med will eventually generate negative long term returns. The profitability progress is the general direction of Spectral Med's change in net profit over the period of time. It can combine multiple indicators of Spectral Med, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 12.9 M | 13.6 M | |
| Operating Income | -11.4 M | -12 M | |
| Net Loss | -15.7 M | -14.9 M | |
| Income Tax Expense | 155 K | 162.8 K | |
| Income Before Tax | -15.5 M | -14.7 M | |
| Total Other Income Expense Net | -4.1 M | -3.9 M | |
| Net Loss | -15.5 M | -14.7 M | |
| Net Loss | -12.9 M | -13.6 M | |
| Interest Income | 72.9 K | 46.4 K | |
| Net Interest Income | -1.3 M | -1.3 M | |
| Change To Netincome | 449.6 K | 675.4 K | |
| Net Loss | (0.06) | (0.06) | |
| Income Quality | 0.68 | 0.84 | |
| Net Income Per E B T | 1.01 | 1.32 |
Spectral Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Spectral Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Spectral Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Spectral Med's important profitability drivers and their relationship over time.
Use Spectral Med in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.Spectral Med Pair Trading
Spectral Med Pair Trading Analysis
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Spectral Med position
In addition to having Spectral Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Spectral Stock
To fully project Spectral Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Spectral Med at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Spectral Med's income statement, its balance sheet, and the statement of cash flows.